Taysha Gene Therapies (TSHA) Interest & Investment Income: 2022-2025
Historic Interest & Investment Income for Taysha Gene Therapies (TSHA) over the last 4 years, with Sep 2025 value amounting to $3.2 million.
- Taysha Gene Therapies' Interest & Investment Income rose 50.40% to $3.2 million in Q3 2025 from the same period last year, while for Sep 2025 it was $8.1 million, marking a year-over-year increase of 12.47%. This contributed to the annual value of $6.9 million for FY2024, which is 94.29% up from last year.
- Per Taysha Gene Therapies' latest filing, its Interest & Investment Income stood at $3.2 million for Q3 2025, which was up 70.47% from $1.9 million recorded in Q2 2025.
- In the past 5 years, Taysha Gene Therapies' Interest & Investment Income registered a high of $3.2 million during Q3 2025, and its lowest value of $9,000 during Q3 2022.
- Moreover, its 3-year median value for Interest & Investment Income was $1.7 million (2024), whereas its average is $1.5 million.
- Its Interest & Investment Income has fluctuated over the past 5 years, first spiked by 12,222.22% in 2023, then decreased by 21.68% in 2025.
- Taysha Gene Therapies' Interest & Investment Income (Quarterly) stood at $199,000 in 2022, then soared by 865.33% to $1.9 million in 2023, then fell by 11.50% to $1.7 million in 2024, then spiked by 50.40% to $3.2 million in 2025.
- Its Interest & Investment Income was $3.2 million in Q3 2025, compared to $1.9 million in Q2 2025 and $1.3 million in Q1 2025.